Published in Med Clin (Barc) on March 02, 1985
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
[Updating of prognostic factors in bladder carcinoma]. Med Clin (Barc) (1991) 1.39
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene (2009) 1.09
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res (1996) 0.97
Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. Breast Cancer Res Treat (2001) 0.96
Mutational study of p16CDKN2/MTS1/INK4A and p57KIP2 genes in hepatocellular carcinoma. Int J Oncol (1998) 0.88
Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Int J Oncol (1999) 0.85
Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer (1998) 0.80
Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Cancer Genet Cytogenet (2001) 0.79
[Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung]. Neurologia (1990) 0.75
[Multiple drug resistance. Biological and clinica implications]. Med Clin (Barc) (1989) 0.75
[Applications to clinico-pathological diagnosis of in situ hybridization]. Med Clin (Barc) (1990) 0.75
[The AIDS virus]. Med Clin (Barc) (1986) 0.75
[Immunopathology (II)]. Med Clin (Barc) (1985) 0.75
[Morphologic changes and pathologic anatomy associated with acquired immune deficiency syndrome]. Med Clin (Barc) (1986) 0.75